Karolina Walczyńska-Dragon, Anna Kurek-Górecka, Wojciech Niemczyk, Zuzanna Nowak, Stefan Baron, Paweł Olczyk, Aleksandra Nitecka-Buchta, Wojciech M Kempa
Background : Temporomandibular disorders (TMDs) are the most prevalent non-dental pain issues in the maxillofacial region. Despite advancements, diagnosing and managing TMDs continues to pose challenges. This study aimed to assess the efficacy of cannabidiol (CBD) formulations, with different concentrations, in patients experiencing sleep bruxism and muscle-related TMDs, with a particular emphasis on their myorelaxant, pain-relieving, and bruxism-reducing properties. Methods : The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMDs) was utilized as the diagnostic framework...
February 29, 2024: Journal of Clinical Medicine